Notizia - Recent Pharma, Healthcare and Biotech Happenings

recent-pharma-biotech-news-updates-for-fosun-biontech-biomarin-Boston-Scientific

Fosun-BioNTech’s COVID-19 vaccine; Multiple Sclerosis research update; Vosoritide nabs FDA review; FDA nods to paclitaxel-coated Ranger balloon for PAD

FDA nods Boston Scientific's paclitaxel-coated Ranger balloon for peripheral artery disease Boston Scientific has received the FDA approval for its Ranger paclitaxel-coated balloon, designed to restrict a patient's systemic exposure to the chemotherapy used to reduce the closure of reopened arteries. The slim-profile balloon comprises of a lower overall dose of the embedded drug, and proprietary coating that transfers the compound into adjoining tissue to obstruct its spread via the body. The Ranger previously secured a CE Mark in 2014; Boston Scientific announced its plans to start the U.S. rollout of the device immediately. The agency approved the balloon d...

Explore More...

Sun Pharma & ICGEB announce collaboration; Boehringer Ingelheim and Lupin Sign deal; Daiichi Sankyo Announces; Catalent Pharma Solutions partners with Samsung Bioepis; Celltrion Healthcare and Teva enters into exclusive business collaboration agreement

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Fosun-BioNTech’s COVID-19 vaccine; Multiple Sclerosis research update; Vosoritide nabs FDA review; FDA nods to paclitaxel-coated Ranger balloon for PAD

Aurobindo takes top generic spot; Valeant unloads Dendreon; Ipsen strikes $1B deal; Takeda shells out $5.2B

Sanofi, Regeneron one step closer; Pharma’s deal; J&J and Actelion deal

Sanofi sues Novo; Allergan gets help; Actelion snubs; Impax CEO Wilkinson out

Pfizer uses; FDA approves; EMA approves; Mylan launches

CDC study reveals; Jevtana receives yes; Herantis secures; Immuno-oncology is not cost-effective

Novartis joins; Sanofi weighs Actelion; Valeant and Takeda’s $10B deal; Astellas scouts pipeline

Glaxo replaces ViiV; Lilly nets; AstraZeneca shuffles off; Gazyva aims to beat

EC grants; Pfizer cuts; 27 medicines sold; Keytruda nabs

More Views & Analysis

Novartis Buys; FDA approves; Mayne Pharma Launches; Oxford Genetics Receives Grant

Novartis eyes; Pfizer considers cashing; Mylan pushes to seal $465M; Valeant with Takeda for deal

Aurobindo’s net profit; LLS selects; Eli Lilly secures; DNA vaccine against Zika

Collaborate for TYG Oncology; GE Healthcare and Valneva collaboration; UPS to Acquire Marken

Fresenius Kabi introduced Bivalirudin; Envigo Launches; Mylan’s MAA accepted; Pricing hit pharma

Sun Pharma Announces Launch; OptiNose files; Opiant obtains rights; Swissmedic approves

Boston Biomedical starts phase III; Martindale receives approval; Merck snagged yes; Nanotechnology to improve HIV

Sun Pharma & ICGEB announce collaboration; Boehringer Ingelheim and Lupin Sign deal; Daiichi Sankyo Announces; Catalent Pharma Solutions partners with Samsung Bioepis; Celltrion Healthcare and Teva enters into exclusive business collaboration agreement

Subscribe to our Updates

Daily

Weekly

Monthly